Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice

Human Molecular Genetics

Volumn 24, Issue 12, 2015, Pages 3481-3496

  Achour, Mayada ^a   Gras, Stéphanie Le ^a   Keime, Céline ^a   Parmentier, Frédéric ^b,c   Lejeune, François Xavier ^b,c   Boutillier, Anne Laurence ^a   Néri, Christian ^b,c   Davidson, Irwin ^a   Merienne, Karine ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Université Pierre et Marie Curie   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN H3K27; RNA POLYMERASE II; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; HISTONE; PROTEIN BINDING; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; ENHANCER REGION; GENE AND NUCLEIC ACID PARAMETERS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HISTONE ACETYLATION; HUNTINGTON CHOREA; MASSIVELY PARALLEL SEQUENCING; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TRANSGENIC MOUSE;

MUS;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONES; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEURONS; PROTEIN BINDING; RNA POLYMERASE II; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84930452523     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv099     Document Type: Article

References (71)

1. Schneider, A., Chatterjee, S., Bousiges, O., Selvi, B.R., Swaminathan, A., Cassel, R., Blanc, F., Kundu, T.K. and Boutillier, A.L. (2013) Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics, 10, 568-588.
2. Seredenina, T. and Luthi-Carter, R. (2012) What have we learned from gene expression profiles in Huntington's disease? Neurobiol. Dis., 45, 83-98.
3. Luthi-Carter, R., Strand, A., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet., 9, 1259-1271.
4. Kuhn, A., Goldstein, D.R., Hodges, A., Strand, A.D., Sengstag, T., Kooperberg, C., Becanovic, K., Pouladi, M.A., Sathasivam, K., Cha, J.H. et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet., 16, 1845-1861.
5. Hodges, A., Strand, A.D., Aragaki, A.K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L.A., Hartog, C., Goldstein, D.R., Thu, D. et al. (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet., 15, 965-977.
6. Hodges, A., Hughes, G., Brooks, S., Elliston, L., Holmans, P., Dunnett, S.B. and Jones, L. (2008) Brain gene expression correlates with changes in behavior in the R6/1 mouse model of Huntington's disease. Genes Brain Behav., 7, 288-299.
7. Desplats, P.A., Kass, K.E., Gilmartin, T., Stanwood, G.D., Woodward, E.L., Head, S.R., Sutcliffe, J.G. and Thomas, E.A. (2006) Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J. Neurochem., 96, 743-757.
8. Vashishtha, M., Ng, C.W., Yildirim, F., Gipson, T.A., Kratter, I.H., Bodai, L., Song, W., Lau, A., Labadorf, A., Vogel-Ciernia, A. et al. (2013) Targeting H3K4 trimethylation in Huntington disease. Proc. Natl Acad. Sci. USA, 110, E3027-E3036.
9. Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.Z., Gohler, H., Wanker, E.E., Bates, G.P., Housman, D.E. and Thompson, L.M. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 97, 6763-6768.
10. Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. and Housman, D. (1999) Insoluble detergent-resistant aggregates form between pathological and non-pathological lengths of polyglutamine in mammalian cells. Proc. Natl Acad. Sci. USA, 96, 11404-11409.
11. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
12. Nucifora, F.C. Jr., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L. et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 291, 2423-2428.
13. McFarland, K.N., Das, S., Sun, T.T., Leyfer, D., Xia, E., Sangrey, G.R., Kuhn, A., Luthi-Carter, R., Clark, T.W., Sadri-Vakili, G. et al. (2012) Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS ONE, 7, e41423.
14. Sadri-Vakili, G., Bouzou, B., Benn, C.L., Kim, M.O., Chawla, P., Overland, R.P., Glajch, K.E., Xia, E., Qiu, Z., Hersch, S.M. et al. (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum. Mol. Genet., 16, 1293-1306.
15. Valor, L.M., Guiretti, D., Lopez-Atalaya, J.P. and Barco, A. (2013) Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J. Neurosci., 33, 10471-10482.
16. Tie, F., Banerjee, R., Stratton, C.A., Prasad-Sinha, J., Stepanik, V., Zlobin, A., Diaz, M.O., Scacheri, P.C. and Harte, P.J. (2009) CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development, 136, 3131-3141.
17. Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., Hanna, J., Lodato, M.A., Frampton, G.M., Sharp, P.A. et al. (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA, 107, 21931-21936.
18. Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S.A., Flynn, R.A. and Wysocka, J. (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature, 470, 279-283.
19. Zentner, G.E., Tesar, P.J. and Scacheri, P.C. (2011) Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res., 21, 1273-1283.
20. Whyte,W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I. and Young, R.A. (2013) Master transcription factors and mediator establish superenhancers at key cell identity genes. Cell, 153, 307-319.
21. Loven, J., Hoke, H.A., Lin, C.Y., Lau, A., Orlando, D.A., Vakoc, C. R., Bradner, J.E., Lee, T.I. and Young, R.A. (2013) Selective inhibition of tumor oncogenes by disruption of superenhancers. Cell, 153, 320-334.
22. Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V., Sigova, A.A., Hoke, H.A. and Young, R.A. (2013) Super-enhancers in the control of cell identity and disease. Cell, 155, 934-947.
23. Chapuy, B., McKeown, M.R., Lin, C.Y., Monti, S., Roemer, M.G., Qi, J., Rahl, P.B., Sun, H.H., Yeda, K.T., Doench, J.G. et al. (2013) Discovery and characterization of super-enhancerassociated dependencies in diffuse large B cell lymphoma. Cancer Cell, 24, 777-790.
24. Plank, J.L. and Dean, A. (2014) Enhancer function: mechanistic and genome-wide insights come together. Mol. Cell, 55, 5-14.
25. Liu,W., Ma, Q.,Wong, K., Li,W., Ohgi, K., Zhang, J., Aggarwal, A.K. and Rosenfeld, M.G. (2013) Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Cell, 155, 1581-1595.
26. Schaukowitch, K., Joo, J.Y., Liu, X.,Watts, J.K., Martinez, C. and Kim, T.K. (2014) Enhancer RNA facilitates NELF release from immediate early genes. Mol. Cell, 56, 29-42.
27. Kala, K., Haugas, M., Lillevali, K., Guimera, J., Wurst, W., Salminen, M. and Partanen, J. (2009) Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons. Development, 136, 253-262.
28. Huang Da, W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
29. McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B., Wenger, A.M. and Bejerano, G. (2010) GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotech., 28, 495-501.
30. Tourette, C., Li, B., Bell, R., O'Hare, S., Kaltenbach, L.S.,Mooney, S.D. and Hughes, R.E. (2014) A large scale huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease. J. Biol. Chem., 289, 6709-6726.
31. Cepeda, C., Ariano, M.A., Calvert, C.R., Flores-Hernandez, J., Chandler, S.H., Leavitt, B.R., Hayden, M.R. and Levine, M.S. (2001) NMDA receptor function in mouse models of Huntington disease. J. Neurosci. Res., 66, 525-539.
32. Hebb, A.L., Robertson, H.A. and Denovan-Wright, E.M. (2004) Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience, 123, 967-981.
33. van Dellen, A., Welch, J., Dixon, R.M., Cordery, P., York, D., Styles, P., Blakemore, C. and Hannan, A.J. (2000) N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice. Neuroreport, 11, 3751-3757.
34. Kwak, H. and Lis, J.T. (2013) Control of transcriptional elongation. Ann. Rev. Genet., 47, 483-508.
35. Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp, P.A. and Young, R.A. (2010) c-Myc regulates transcriptional pause release. Cell, 141, 432-445.
36. Bruce, A.W., Donaldson, I.J., Wood, I.C., Yerbury, S.A., Sadowski, M.I., Chapman, M., Gottgens, B. and Buckley, N.J. (2004) Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc. Natl Acad. Sci. USA, 101, 10458-10463.
37. Wang, H.F. and Liu, F.C. (2005) Regulation of multiple dopamine signal transduction molecules by retinoids in the developing striatum. Neuroscience, 134, 97-105.
38. Kim, T.K., Hemberg, M., Gray, J.M., Costa, A.M., Bear, D.M., Wu, J., Harmin, D.A., Laptewicz, M., Barbara-Haley, K., Kuersten, S. et al. (2010) Widespread transcription at neuronal activityregulated enhancers. Nature, 465, 182-187.
39. He, A., Gu, F., Hu, Y., Ma, Q., Yi Ye, L., Akiyama, J.A., Visel, A., Pennacchio, L.A. and Pu, W.T. (2014) Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat. Commun., 5, 4907-4918.
40. Mansour, M.R., Abraham, B.J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A.D., Etchin, J., Lawton, L., Sallan, S.E., Silverman, L.B. et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science, 346, 1373-1377.
41. Tie, F., Banerjee, R., Saiakhova, A.R., Howard, B., Monteith, K.E., Scacheri, P.C., Cosgrove, M.S. and Harte, P.J. (2014) Trithorax monomethylates histone H3K4 and interacts directly with CBP to promote H3K27 acetylation and antagonize Polycomb silencing. Development, 141, 1129-1139.
42. Outchkourov, N.S., Muino, J.M., Kaufmann, K., van Ijcken, W.F., Groot Koerkamp, M.J., van Leenen, D., de Graaf, P., Holstege, F.C., Grosveld, F.G. and Timmers, H.T. (2013) Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep., 3, 1071-1079.
43. Seong, I.S., Woda, J.M., Song, J.J., Lloret, A., Abeyrathne, P.D., Woo, C.J., Gregory, G., Lee, J.M., Wheeler, V.C., Walz, T. et al. (2010) Huntingtin facilitates polycomb repressive complex 2. Hum. Mol. Genet., 19, 573-583.
44. Biagioli, M., Ferrari, F., Mendenhall, E.M., Zhang, Y., Erdin, S., Vijayvargia, R., Vallabh, S.M., Solomos, N., Manavalan, P., Ragavendran, A. et al. (2015) Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum. Mol. Genet., 24, 2442-2457.
45. Bai, G., Cheung, I., Shulha, H.P., Coelho, J.E., Li, P., Dong, X., Jakovcevski, M., Wang, Y., Grigorenko, A., Jiang, Y. et al. (2015) Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains. Hum. Mol. Genet., 24, 1441-1456.
46. Dowen, J.M., Bilodeau, S., Orlando, D.A., Hubner, M.R., Abraham, B.J., Spector, D.L. and Young, R.A. (2013) Multiple structural maintenance of chromosome complexes at transcriptional regulatory elements. Stem Cell Rep., 1, 371-378.
47. Hendrix, D.A., Hong, J.W., Zeitlinger, J., Rokhsar, D.S. and Levine, M.S. (2008) Promoter elements associated with RNA Pol II stalling in the Drosophila embryo. Proc. Natl Acad. Sci. USA, 105, 7762-7767.
48. Zeitlinger, J., Stark, A., Kellis, M., Hong, J.W., Nechaev, S., Adelman, K., Levine, M. and Young, R.A. (2007) RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet., 39, 1512-1516.
49. Muse, G.W., Gilchrist, D.A., Nechaev, S., Shah, R., Parker, J.S., Grissom, S.F., Zeitlinger, J. and Adelman, K. (2007) RNA polymerase is poised for activation across the genome. Nat. Genet., 39, 1507-1511.
50. Hah, N., Benner, C., Chong, L.W., Yu, R.T., Downes, M. and Evans, R.M. (2015) Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc. Natl Acad. Sci. USA, 112, E297-E302.
51. Smith, E. and Shilatifard, A. (2014) Enhancer biology and enhanceropathies. Nat. Struct. Mol. Biol., 21, 210-219.
52. Chatterjee, S., Mizar, P., Cassel, R., Neidl, R., Selvi, B.R., Mohankrishna, D.V., Vedamurthy, B.M., Schneider, A., Bousiges, O., Mathis, C. et al. (2013) A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J. Neurosci., 33, 10698-10712.
53. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
54. Goula, A.V., Berquist, B.R., Wilson, D.M. III, Wheeler, V.C., Trottier, Y. and Merienne, K. (2009) Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet., 5, e1000749.
55. Trapnell, C., Pachter, L. and Salzberg, S.L. (2009) TopHat:discovering splice junctions with RNA-Seq. Bioinformatics, 25, 1105-1111.
56. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
57. Anders, S., Pyl, P.T. and Huber, W. (2015) HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics, 31, 166-169.
58. Love, M.I., Huber,W. and Anders, S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550-571.
59. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B, 57, 289-300.
60. Anders, S. and Huber, W. (2010) Differential expression analysis for sequence count data. Genome Biol., 11, R106.
61. Goula, A.V., Stys, A., Chan, J.P., Trottier, Y., Festenstein, R. and Merienne, K. (2012) Transcription elongation and tissuespecific somatic CAG instability. PLoS Genet., 8, e1003051.
62. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137.
63. Zang, C., Schones, D.E., Zeng, C., Cui, K., Zhao, K. and Peng,W. (2009) A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics, 25, 1952-1958.
64. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H. and Glass, C.K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
65. Ye, T., Krebs, A.R., Choukrallah, M.A., Keime, C., Plewniak, F., Davidson, I. and Tora, L. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res., 39, e35.
66. Zhu, L.J., Gazin, C., Lawson, N.D., Pages, H., Lin, S.M., Lapointe, D.S. and Green, M.R. (2010) ChIPpeakAnno: a bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics, 11, 237.
67. Lejeune, F.X., Mesrob, L., Parmentier, F., Bicep, C., Vazquez-Manrique, R.P., Parker, J.A., Vert, J.P., Tourette, C. and Neri, C. (2012) Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons. BMC Genomics, 13, 91.
68. Kim, W.K., Krumpelman, C. and Marcotte, E.M. (2008) Inferring mouse gene functions from genomic-scale data using a combined functional network/classification strategy. Genome Biol., 9(Suppl 1), S5.
69. Kanehisa, M. and Goto, S. (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30.
70. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genet., 25, 25-29.
71. Grant, C.E., Bailey, T.L. and Noble,W.S. (2011) FIMO: scanning for occurrences of a given motif. Bioinformatics, 27, 1017-1018.